Ami Organics Ltd - 543349 - Recording Of The Earnings Call Held On February 12, 2024
Recording of the Earnings Call held on February 12, 2024 as attached.12-02-2024
12-02-2024
Ami Organics Results Earnings Call for Q3FY24
Conference Call with Ami Organics Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.12-02-2024
Ami Organics Ltd - 543349 - Statement Of Deviation & Variation For The Quarter Ended December 31, 2023.
Statement of Deviation & Variation for the quarter ended December 31, 2023 as attached.12-02-2024
Ami Organics Ltd - 543349 - Sustainability Report For The FY 2022-23
Sustainability Report for the FY 2022-23 is attached.12-02-2024
Q3FY24 Quarterly Result Announced for Ami Organics Ltd.
Pharmaceutical company Ami Organics announced Q3FY24 results: Financial Highlights for Q3FY24: Revenue from operations for Q3FY24 grew by 9.2% YoY to Rs 1,664 million. The gross margin for the quarter was at 42.9% as compared to 46% in Q3FY23 and 41% in Q2FY24. Gross margins contracted 303 basis points YoY but expanded by 190 bps sequentially. Gross margins were driven by unfavourable product mix and pricing pressure. EBITDA for the quarter came at Rs 265 million, down 13.9% YoY compared to Rs 308 million in Q3FY23 and up 6.8% QoQ compared to Rs 248 million in Q2FY24. EBITDA margin for the quarter was at 15.9% as compared to 20.2% in Q3FY23 and 14.4% in Q2FY24. EBITDA margins degrew by 430bps YoY and grew by 153 bps sequentially. EBITDA margins were largely driven by gross margins. PAT for the quarter was Rs 178 million. The PAT margin for the quarter was 10.7% Commenting on the results, Mr. Naresh Patel, Executive Chairman & Managing Director, Ami Organics Limited, said, “In the face of a challenging landscape of the chemical industry, I am pleased to report that we have been able to deliver quality growth in Q3FY23 with our revenue from operations growing 9.2% YoY to Rs. 1,664million. This growth is underpinned by robust volume growth of 25%, indicating strong business traction. During the quarter, we further solidified our relationship with Fermion by signing an agreement for two additional advanced intermediates for their APIs. This milestone reflects AMI Organics’ prowess in fostering enduring client relationships, ably supported by strong R&D; and manufacturing strengths. Additionally, we also inaugurated a state-of-the-art, technology-driven plant at our Ankleshwar site, designed to meet the growing demand in the pharmaceutical intermediate business. I am also excited to share that we have signed an MOU with a global manufacturer of electrolytes for the manufacturing of electrolytes for battery cells and allied materials. In this context, we have also signed an MoU with the Government of Gujarat for investment amounting up to Rs 300 crores for setting up of a dedicated manufacturing facility for electrolytes business in Gujarat. Despite the industry headwinds, we remain confident of closing the year with healthy growth. I would also like to highlight that the various initiatives we have taken in FY23 and FY24 enhances our revenue visibility for FY25 and beyond, bolstering our confidence in our potential for stronger growth in coming years.” Result PDF12-02-2024
Ami Organics Ltd - 543349 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation for Q3 FY24 is herewith attached.12-02-2024
Ami Organics Ltd - 543349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release discussing Q3 FY24 financial results is attached.12-02-2024
Ami Organics Ltd - 543349 - Unaudited Standalone And Consolidated Financial Results For The Third Quarter And Nine Months Ended December 31, 2023
Unaudited Standalone and consolidated Financial Results for the third quarter and nine months ended December 31, 2023 as approved by Board is herewith attached.12-02-2024
Ami Organics Ltd - 543349 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 12, 2024
The Board of Directors of the Company at their meeting held on Monday, February 12, 2024, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company for the third quarter & nine months ended December 31, 202312-02-2024
Ami Organics Ltd - 543349 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform that the Company''s officials will attend "IIFL Enterprising India 2024 conference" on February 16, 2024 as per the details attached.10-02-2024